Eigengene
Eigengene uses AI to connect the cancer genome with treatment outcomes. It analyzes cancer whole-genome sequencing data with AI/ML algorithms. It is a B2B platform for genomic cancer research and clinical decision support. The system focuses on genomics data workflows and integrates core AI/ML technology for sequencing data. The market potential grows as precision oncology expands and cancer genomics becomes more routine in research and clinical settings.
Eigengene
Eigengene uses AI to connect the cancer genome with treatment outcomes. It analyzes cancer whole-genome sequencing data with AI/ML algorithms. It is a B2B platform for genomic cancer research and clinical decision support. The system focuses on genomics data workflows and integrates core AI/ML technology for sequencing data. The market potential grows as precision oncology expands and cancer genomics becomes more routine in research and clinical settings.